Cargando…

A novel immune-related lncRNA pair signature for prognostic prediction and immune response evaluation in gastric cancer: a bioinformatics and biological validation study

BACKGROUND: Gastric cancer (GC), the most commonly diagnosed cancer worldwide with poor 5-year survival rate in advanced stages. Although immune-related and survival-related biomarkers, which typically comprise aberrantly expressed long non-coding RNAs (lncRNAs) and genes, have been identified, ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jun, Wang, Beidi, Zhou, Biting, Chen, Jing, Qi, Jia, Shi, Le, Yu, Shaojun, Chen, Guofeng, Kang, Muxing, Jin, Xiaoli, Wang, Lie, Xu, Jinghong, Zhu, Linghua, Chen, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832759/ https://www.ncbi.nlm.nih.gov/pubmed/35144613 http://dx.doi.org/10.1186/s12935-022-02493-2

Ejemplares similares

A novel prognostic signature of immune‐related genes for patients with colorectal cancer
por: Wang, Jun, et al.
Publicado: (2020)

A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma
por: Bu, Xiaoyun, et al.
Publicado: (2022)

Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma
por: Qin, Yuan, et al.
Publicado: (2022)

An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

Comprehensive Analysis of an Individualized Immune-Related lncRNA Pair Signature in Gastric Cancer
por: Nie, Chuang, et al.
Publicado: (2022)

Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature
por: Qi, Xiangjun, et al.
Publicado: (2021)

Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma
por: Yao, Jie, et al.
Publicado: (2021)

Immune-related lncRNA classification of head and neck squamous cell carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2022)

A novel prognostic cancer-related lncRNA signature in papillary renal cell carcinoma
por: Chen, Binghai, et al.
Publicado: (2021)

Prognostic value of a five-lncRNA signature in esophageal squamous cell carcinoma
por: zhang, Lan, et al.
Publicado: (2020)

A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures
por: Jin, Lipeng, et al.
Publicado: (2020)

Identification and potential mechanisms of a 4-lncRNA signature that predicts prognosis in patients with laryngeal cancer
por: Zhang, Guihai, et al.
Publicado: (2019)

Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

Immune-related lncRNA pairs as novel signature to predict prognosis and immune landscape in melanoma patients
por: Li, Zhehong, et al.
Publicado: (2022)

Suppression of endothelial cell migration by tumor associated macrophage-derived exosomes is reversed by epithelial ovarian cancer exosomal lncRNA
por: Wu, Quanfeng, et al.
Publicado: (2017)

A novel prognostic signature of immune-related lncRNA pairs in lung adenocarcinoma
por: Liu, Yang, et al.
Publicado: (2021)

Joint analysis of lncRNA m(6)A methylome and lncRNA/mRNA expression profiles in gastric cancer
por: Lv, Zhi, et al.
Publicado: (2020)

Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC1
por: Chen, Xing, et al.
Publicado: (2019)

Six-lncRNA Immune Prognostic Signature for Cervical Cancer
por: Chen, Qian, et al.
Publicado: (2020)

An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma
por: Zhao, Xiaowen, et al.
Publicado: (2022)

A signature of seven immune‐related genes predicts overall survival in male gastric cancer patients
por: Xu, Xin, et al.
Publicado: (2021)

lncRNA DLEU2 promotes gastric cancer progression through ETS2 via targeting miR-30a-5p
por: Han, Shuyi, et al.
Publicado: (2021)

Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinoma
por: Zhuang, Jinman, et al.
Publicado: (2022)

Comprehensive bioinformatics analysis reveals potential lncRNA biomarkers for overall survival in patients with hepatocellular carcinoma: an on-line individual risk calculator based on TCGA cohort
por: Zhang, Zhiqiao, et al.
Publicado: (2019)

Mechanistic study of lncRNA UCA1 promoting growth and cisplatin resistance in lung adenocarcinoma
por: Fu, Jiali, et al.
Publicado: (2021)

An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma
por: Qian, Lvsheng, et al.
Publicado: (2022)

A novel signature to predict thyroid cancer prognosis and immune landscape using immune-related LncRNA pairs
por: Song, Bo, et al.
Publicado: (2022)

ALKBH5-mediated m(6)A demethylation of lncRNA PVT1 plays an oncogenic role in osteosarcoma
por: Chen, Shuo, et al.
Publicado: (2020)

LncRNA SNHG12 regulates the radiosensitivity of cervical cancer through the miR-148a/CDK1 pathway
por: Wang, Chen, et al.
Publicado: (2020)

LncRNA JPX promotes cervical cancer progression by modulating miR-25-3p/SOX4 axis
por: Chen, Xia, et al.
Publicado: (2020)

Immune Subtype Profiling and Establishment of Prognostic Immune-Related lncRNA Pairs in Human Ovarian Cancer
por: Wang, Xingling, et al.
Publicado: (2022)

Calculated identification of mutator-derived lncRNA signatures of genomic instability to predict the clinical outcome of muscle-invasive bladder cancer
por: Liang, Yingchun, et al.
Publicado: (2021)

Identification of prognostic immune-related lncRNA signature predicting the overall survival for colorectal cancer
por: Li, Jianxin, et al.
Publicado: (2023)

Stemness-related LncRNA pair signature for predicting therapy response in gastric cancer
por: Jiang, Quan, et al.
Publicado: (2021)

Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma
por: Kong, Weihao, et al.
Publicado: (2020)

An angiogenesis-related lncRNA signature predicts the immune microenvironment and prognosis of breast cancer
por: Wang, Ya-Wen, et al.
Publicado: (2023)

Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma
por: Sun, Jian-Xuan, et al.
Publicado: (2021)

Prognostic value and immune infiltration of novel signatures in colon cancer microenvironment
por: Lin, Yilin, et al.
Publicado: (2021)

LncRNA KCNQ1OT1 sponges miR-15a to promote immune evasion and malignant progression of prostate cancer via up-regulating PD-L1
por: Chen, Qi-Hua, et al.
Publicado: (2020)

LncRNA TRG-AS1 stimulates hepatocellular carcinoma progression by sponging miR-4500 to modulate BACH1
por: Sun, Xuehu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8kjrtjbruh0mtkjb02dukqho26